2022 ICD-10-CM Code D09.19

Carcinoma in situ of other urinary organs

Version 2021

Valid for Submission

ICD-10:D09.19
Short Description:Carcinoma in situ of other urinary organs
Long Description:Carcinoma in situ of other urinary organs

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified sites (D09)

D09.19 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of other urinary organs. The code D09.19 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.

The ICD-10-CM code D09.19 might also be used to specify conditions or terms like carcinoma in situ of kidney, carcinoma in situ of paraurethral glands, carcinoma in situ of renal pelvis, carcinoma in situ of ureter, carcinoma in situ of urethra , carcinoma of urethra, etc.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: bulbourethral gland ; calyx, renal ; Cowper's gland ; junction pelviureteric ; kidney (parenchymal) ; kidney (parenchymal) calyx ; kidney (parenchymal) hilus ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert D09.19 to ICD-9 Code

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D09.19 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The code D09.19 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»bulbourethral gland
C68.0C79.19D09.19D30.4D41.3D49.59
»calyx, renal
C65.C79.0D09.19D30.1D41.1D49.51
»Cowper's gland
C68.0C79.19D09.19D30.4D41.3D49.59
»junction
  »pelviureteric
C65.C79.0D09.19D30.1D41.1D49.59
»kidney (parenchymal)
C64.C79.0D09.19D30.0D41.0D49.51
»kidney (parenchymal)
  »calyx
C65.C79.0D09.19D30.1D41.1D49.51
»kidney (parenchymal)
  »hilus
C65.C79.0D09.19D30.1D41.1D49.51
»kidney (parenchymal)
  »pelvis
C65.C79.0D09.19D30.1D41.1D49.51
»paraurethral
  »gland
C68.1C79.19D09.19D30.8D41.8D49.59
»parenchyma, kidney
C64.C79.0D09.19D30.0D41.0D49.51
»pelvis, pelvic
  »renal
C65.C79.0D09.19D30.1D41.1D49.51
»prostate (gland)
  »utricle
C68.0C79.19D09.19D30.4D41.3D49.59
»renal
C64.C79.0D09.19D30.0D41.0D49.51
»renal
  »calyx
C65.C79.0D09.19D30.1D41.1D49.51
»renal
  »hilus
C65.C79.0D09.19D30.1D41.1D49.51
»renal
  »parenchyma
C64.C79.0D09.19D30.0D41.0D49.51
»renal
  »pelvis
C65.C79.0D09.19D30.1D41.1D49.51
»Skene's gland
C68.1C79.19D09.19D30.8D41.8D49.59
»ureter, ureteral
C66.C79.19D09.19D30.2D41.2D49.59
»urethra, urethral (gland)
C68.0C79.19D09.19D30.4D41.3D49.59
»urinary organ or system
  »specified sites NEC
C68.8C79.19D09.19D30.8D41.8D49.59
»utricle, prostatic
C68.0C79.19D09.19D30.4D41.3D49.59

Information for Patients


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)